Detalhe da pesquisa
1.
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.
Cell
; 169(4): 597-609.e11, 2017 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475892
2.
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
Immunity
; 55(12): 2419-2435.e10, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370711
3.
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.
Immunity
; 55(6): 998-1012.e8, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447092
4.
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Nature
; 588(7839): 682-687, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045718
5.
Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Nature
; 628(8008): E2, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565636
6.
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
Proc Natl Acad Sci U S A
; 117(18): 9865-9875, 2020 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321830
7.
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
Science
; 377(6606): eabq0839, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857620
8.
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models.
bioRxiv
; 2022 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378752
9.
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins.
bioRxiv
; 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132412
10.
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
NPJ Vaccines
; 6(1): 126, 2021 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697307
11.
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
Science
; 371(6530): 735-741, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436524
12.
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
; 36(13): 109760, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534459
13.
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
bioRxiv
; 2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236016
14.
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
bioRxiv
; 2021 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948592
15.
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.
J Exp Med
; 218(5)2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831141
16.
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies.
bioRxiv
; 2020 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869026
17.
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.
Cell Rep
; 25(6): 1385-1394.e7, 2018 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403995
18.
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
; 37(12): 110188, 2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936878